Ghost Tree Capital, LLC Bridge Bio Pharma, Inc. Transaction History
Ghost Tree Capital, LLC
- $267 Million
- Q3 2024
A detailed history of Ghost Tree Capital, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 175,000 shares of BBIO stock, worth $5.99 Million. This represents 1.67% of its overall portfolio holdings.
Number of Shares
175,000
Previous 140,000
25.0%
Holding current value
$5.99 Million
Previous $3.55 Million
25.63%
% of portfolio
1.67%
Previous 1.45%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
294Shares Held
171MCall Options Held
10.4MPut Options Held
2.36M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$864 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$859 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$486 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$426 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$208 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.07B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...